Global, regional, and national disease burden of lymphoma and leukemia attributable to high body mass index: from 1990 to 2021.

ABSTRACT:

Background

Lymphoma and leukemia were the most common hematological malignancies worldwide. Metabolic factors, such as high body mass index, are potential risk factors for various cancers. This study aimed to analyze the disease burden and the incidence trend of non-Hodgkin and acute leukemia attributable to high BMI around the world from 1990 to 2021.

Methods

Using the data released by the Global Burden of Disease study 2021 (GBD 2021), we analyze the disease burden of non-Hodgkin lymphoma and acute leukemia attributable to high BMI from 1990 to 2021 via morbidity, death, disability-adjusted life years (DALY), and predict the obesity-related death trend in for the next 20 years (2022-2046).

Results

The death cases of non-Hodgkin lymphoma, acute myeloid leukemia and a

SUBMITTER: Zhou L 

PROVIDER: S-EPMC12328193 | biostudies-literature | 2025

REPOSITORIES: biostudies-literature